Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia

被引:416
作者
Stein, I
Itin, A
Einat, P
Skaliter, R
Grossman, Z
Keshet, E [1 ]
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel
[2] QBI Enterprises, IL-74106 Ness Ziona, Israel
关键词
D O I
10.1128/MCB.18.6.3112
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF) is a hypoxia inducible angiogenic growth factor that promotes compensatory angiogenesis in circumstances of oxygen shortage. The requirement for translational regulation of VEGF is imposed by the cumbersome structure of the 5' untranslated region (5'UTR), which is incompatible with efficient translation by ribosomal scanning, and by the physiologic requirement for maximal VEGF production under conditions of hypoxia, where overall protein synthesis is compromised. Using bicistronic reporter gene constructs, we show that the 1,014-bp 5'UTR of VEGF contains a functional internal ribosome entry site (IRES), Efficient cap-independent translation is maintained under hypoxia, thereby securing efficient production of VEGF even under unfavorable stress conditions. To identify sequences within the 5'UTR required for maximal IRES activity, deletion mutants were analyzed. Elimination of the majority (851 nucleotides) of internal 5'UTR sequences not only maintained full IRES activity but also generated a significantly more potent IRES, Activity of the 163-bp long "improved" IRES element was abrogated, however, following substitution of a few bases near the 5' terminus as well as substitutions close to the translation start codon, Both the full-length 5'UTR and its truncated version function as translational enhancers in the context of a monocistronic mRNA.
引用
收藏
页码:3112 / 3119
页数:8
相关论文
共 41 条
  • [1] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [2] VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY
    ALON, T
    HEMO, I
    ITIN, A
    PEER, J
    STONE, J
    KESHET, E
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1024 - 1028
  • [3] DIFFERENTIATED RAT GLIAL CELL STRAIN IN TISSUE CULTURE
    BENDA, P
    LIGHTBODY, J
    SATO, G
    LEVINE, L
    SWEET, W
    [J]. SCIENCE, 1968, 161 (3839) : 370 - +
  • [4] Bernstein J, 1997, J BIOL CHEM, V272, P9356
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [7] CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P529
  • [8] Ehrenfeld E., 1996, TRANSLATIONAL CONTRO, P549
  • [9] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
    Ferrara, N
    CarverMoore, K
    Chen, H
    Dowd, M
    Lu, L
    OShea, KS
    PowellBraxton, L
    Hillan, KJ
    Moore, MW
    [J]. NATURE, 1996, 380 (6573) : 439 - 442
  • [10] Forsythe JA, 1996, MOL CELL BIOL, V16, P4604